Constar to Present DiamondClear(TM) at PET Strategies Conference
19 Septembre 2005 - 2:00PM
Business Wire
Constar International Inc. (NASDAQ:CNST), a leading producer of PET
(polyethylene terephthalate) bottles for the beverage and food
markets will present an update on the development of
DiamondClear(TM) oxygen scavenging technology at the PET Strategies
Conference scheduled for November 29- December 1, 2005, hosted by
Packaging Strategies. DiamondClear is an excellent oxygen
scavenging material that is blended in a monolayer PET bottle.
Michael Hoffman, Constar's President and CEO commented,
"DiamondClear represents a breakthrough in PET oxygen scavenging
technology by offering both the clarity of glass and an economical
monolayer structure. We believe DiamondClear is the right answer
for food and beverage brand owners that are looking to transition
their oxygen sensitive products to consumer friendly PET." As the
DiamondClear material is blended at the preform injection stage,
the technology works equally well with one-step and two-step
injection stretch blow molding operations, eliminating the need for
high cost co-injection equipment necessary for multi-layer barrier
systems. And, unlike systems to apply internal or external barrier
coatings, DiamondClear preforms can be produced centrally and
economically shipped to any blowing location. Constar believes that
"barrier in the preform" solutions provide scalability and
flexibility that broadens the potential of this new technology.
Unlike currently available monolayer scavenger systems,
DiamondClear produces a bottle with clarity equal to plain PET and
with higher gloss. About Constar: Philadelphia based Constar
International Inc. is a leading global producer of PET
(polyethylene terephthalate) plastic containers for food, soft
drinks and water. The company provides full service packaging
solutions, from product design and engineering to ongoing customer
support. Its customers include many of the world's leading branded
consumer products companies. Cautionary Note Regarding
Forward-Looking Statements Except for historical information, all
information in this press release consists of forward-looking
statements within the meaning of the federal securities laws. These
forward-looking statements involve a number of risks, uncertainties
and other factors, which may cause the actual results to be
materially different from those expressed or implied in the
forward-looking statements. Important factors that could cause the
statements in this release to differ include the successful
commercialization of DiamondClear technology and the obtainment of
all required regulatory approvals. Other important factors are
discussed under the caption "Cautionary Statement Regarding Forward
Looking Statements" in the Company's Form 10-K Annual Report for
the year ended December 31, 2004 and in subsequent filings with the
Securities and Exchange Commission made prior to or after the date
hereof. The Company does not intend to review or revise any
particular forward-looking statement in light of future events.
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur Constar International Inc.